Matches in Wikidata for { <http://www.wikidata.org/entity/Q66033805> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q66033805 description "clinical trial" @default.
- Q66033805 description "ensayu clínicu" @default.
- Q66033805 description "klinisch onderzoek" @default.
- Q66033805 description "клінічне випробування" @default.
- Q66033805 description "կլինիկական փորձարկում" @default.
- Q66033805 name "Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes" @default.
- Q66033805 name "Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes" @default.
- Q66033805 type Item @default.
- Q66033805 label "Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes" @default.
- Q66033805 label "Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes" @default.
- Q66033805 prefLabel "Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes" @default.
- Q66033805 prefLabel "Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes" @default.
- Q66033805 P1050 Q66033805-D04CE9EB-F370-4678-BC6B-CFA2B5E8B4C9 @default.
- Q66033805 P1132 Q66033805-6F6B93F1-FE84-4FDA-AD25-1A65658EB031 @default.
- Q66033805 P1476 Q66033805-81DF1627-AD63-4D73-B7F7-E48924522A89 @default.
- Q66033805 P17 Q66033805-5619544D-AC93-43FF-A832-073E438FCF6A @default.
- Q66033805 P17 Q66033805-B8DE7055-43DB-47C3-8200-D4C3282EA785 @default.
- Q66033805 P2899 Q66033805-7DB28738-379D-4A82-AD42-C0B657C8287E @default.
- Q66033805 P3098 Q66033805-CB445D3D-5422-421C-B284-169A59E82DC0 @default.
- Q66033805 P31 Q66033805-B1036F6B-2F93-4184-A57D-676535CD5024 @default.
- Q66033805 P4135 Q66033805-DD85BFB0-AB1F-4FBF-ABC0-CF994ACF5925 @default.
- Q66033805 P580 Q66033805-1C26C2A7-4300-47C7-B916-5B4208F2CDC6 @default.
- Q66033805 P582 Q66033805-53407E40-0378-4A6F-8B44-39CA7DC813B3 @default.
- Q66033805 P6099 Q66033805-F040B5B5-666C-4773-9540-E35451FD3E7B @default.
- Q66033805 P6153 Q66033805-0CA984BC-B650-4626-8D7B-2E9B89633B6E @default.
- Q66033805 P8363 Q66033805-0293A0F4-3B86-4CA9-A853-F7CD4840CD66 @default.
- Q66033805 P859 Q66033805-AB45A013-BEAC-42C1-8739-F788AE8878EA @default.
- Q66033805 P1050 Q12206 @default.
- Q66033805 P1132 "+717" @default.
- Q66033805 P1476 "Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes" @default.
- Q66033805 P17 Q183 @default.
- Q66033805 P17 Q30 @default.
- Q66033805 P2899 "+18" @default.
- Q66033805 P3098 "NCT00099918" @default.
- Q66033805 P31 Q30612 @default.
- Q66033805 P4135 "+80" @default.
- Q66033805 P580 "2004-05-01T00:00:00Z" @default.
- Q66033805 P582 "2005-09-01T00:00:00Z" @default.
- Q66033805 P6099 Q42824827 @default.
- Q66033805 P6153 Q507154 @default.
- Q66033805 P8363 Q78089383 @default.
- Q66033805 P859 Q507154 @default.